- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7507
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR ; volume:36 ; number:2-4 ; day:31 ; month:10 ; year:2009 ; pages:209-222 ; date:12.2009
Applied magnetic resonance ; 36, Heft 2-4 (31.10.2009), 209-222, 12.2009
- Urheber
-
Sepkhanova, I.
Drescher, M.
Meeuwenoord, N. J.
Limpens, R. W. A. L.
Koning, R. I.
Filippov, D. V.
Huber, M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00723-009-0019-1
- URN
-
urn:nbn:de:101:1-2023050721210186140048
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sepkhanova, I.
- Drescher, M.
- Meeuwenoord, N. J.
- Limpens, R. W. A. L.
- Koning, R. I.
- Filippov, D. V.
- Huber, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Oxidation destabilizes toxic amyloid beta peptide aggregation
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Structural basis of Alzheimer β -amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity
Amyloid aggregation of spin-labeled β-lactoglobulin. Part II : Identification of spin-labeled protein and peptide sequences after amyloid aggregation
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β‐peptide
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
![Identification of sequences of the interaction interface β-amyloid peptide [beta-amyloid peptide] Aβ [Abeta] and islet amyloid polypeptide (IAPP) and synthesis and characterization of IAPP-derived inhibitors of Aβ aggregation [Abeta aggregation]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Identification of sequences of the interaction interface β-amyloid peptide [beta-amyloid peptide] Aβ [Abeta] and islet amyloid polypeptide (IAPP) and synthesis and characterization of IAPP-derived inhibitors of Aβ aggregation [Abeta aggregation]
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Oxidation destabilizes toxic amyloid beta peptide aggregation
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Structural basis of Alzheimer β -amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity
Amyloid aggregation of spin-labeled β-lactoglobulin. Part II : Identification of spin-labeled protein and peptide sequences after amyloid aggregation
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β‐peptide
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Identification of sequences of the interaction interface β-amyloid peptide [beta-amyloid peptide] Aβ [Abeta] and islet amyloid polypeptide (IAPP) and synthesis and characterization of IAPP-derived inhibitors of Aβ aggregation [Abeta aggregation]
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Oxidation destabilizes toxic amyloid beta peptide aggregation
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Structural basis of Alzheimer β -amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity
Amyloid aggregation of spin-labeled β-lactoglobulin. Part II : Identification of spin-labeled protein and peptide sequences after amyloid aggregation
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β‐peptide
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Identification of sequences of the interaction interface β-amyloid peptide [beta-amyloid peptide] Aβ [Abeta] and islet amyloid polypeptide (IAPP) and synthesis and characterization of IAPP-derived inhibitors of Aβ aggregation [Abeta aggregation]